AzTrials
AzTrials

Degenerative Lumbar Spinal StenosisNORDSTEN/OSNCT03562936

The NORDSTEN Studies/The Observational Cohort Study

An observational study of Degenerative Lumbar Spinal Stenosis and Degenerative Spondylolisthesis, run by Haukeland University Hospital at 1 site in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The NORDSTEN- OS(Observational study) aim to study the natural course in patients with mild to moderate symptomatic lumbar spinal stenosis with and without degenerative spondylolisthesis. 10 years follow-up is planned. Read more about this study

Who is it for?
Ages 18 to 80 years
How many people
284 participants
Where
1 siteNorway
Study dates
Feb 2014to Oct 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients with symptomatic LSS with and without LDS referred to the participating orthopedic- or neurosurgical departments will be eligible for inclusion in the observational cohort. The burden of symptoms is considered not to be severe enough to opt for surgical treatment, and this conclusion is made through informed shared decision-making between surgeon and patient. Patients will be given verbal and written information about this observational study. If willing to participate, the patients sign an informed consent. The treatment of these patients will be pragmatic "usual care". There will not be any planned specific conservative treatment, but the surgeon can recommend specific conservative treatments in any case if preferred

Who may be able to join

  • Presence of clinical symptoms of spinal stenosis. Neurogenic claudication or radiating pain to one or both lower limbs
  • Radiological findings corresponding to the clinical symptoms of LSS. Central stenosis or lateral recess stenosis with or without degenerative spondylolisthesis
  • Able to understand Norwegian language, both spoken and written
  • Able to give informed consent and to answer the questionnaires
  • Over 18 years of age

Who cannot join

  • Not willing to give written consent
  • Participation in other clinical trial that may interfere with this trial
  • American Society of Anesthesiologists (ASA) 4 or 5
  • Age older than 80 years
  • Not able to comply fully with the protocol, including treatment, follow-up or study procedures (psychosocially, mentally and physically)
  • Presence of cauda equina syndrome (bowel and bladder dysfunction) or complete motor deficit
Show all 11Show fewer
  • Presence of an isthmic defect in pars interarticularis
  • Former fracture of the thoracolumbar region
  • Previous surgery in the lumbar region
  • Distinct symptoms in one or both legs due to other diseases, e.g. polyneuropathy, vascular claudication or osteoarthritis
  • Lumbosacral scoliosis of more than 20 degrees verified on standing x-ray AP-view

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Kysthospitalet i Hagavik, Orthopeadic clinic, Haukeland University Hospital

    Hagavik, 5217

Other trials in Norway

About this study

Official title: Prospective Observational Cohort Study of Patients With Symptomatic Degenerative Spinal Stenosis With and Without Degenerative Spondylolisthesis Not Scheduled for Surgery

The NORDSTEN- OS(Observational study) aim to study the natural course in patients with mild to moderate symptomatic lumbar spinal stenosis with and without degenerative spondylolisthesis. 10 years follow-up is planned.

The NORDSTEN-OS is one of three studies in The NORwegian Degenerative Spondylolisthesis and Spinal STENosis studies.

Read more

The two other studies are:

NORDSTEN-SST (Spinal stenosis trial) (NCT02007083); a randomized controlled trial comparing the clinical and radiological results in three different decompression techniques in patients with lumbar spinal stenosis. The NORDSTEN-DS (Degenerative spondylolisthesis) (NCT02051374); a randomized controlled trial comparing the outcome of surgery with decompression without fixation and decompression with fixation in patients with lumbar spinal stenosis and concurrent degenerative spondylolisthesis.

Read the detailed description

Objectives:

  1. A longitudinal observation of clinical- and radiological development with 5- and 10 years follow-up. Variables predicting clinical deterioration or improvement, and outcome measurements including time from inclusion to time for surgery, will be analyzed. We will use predictive models appropriate to the type of data each prognostic outcome measure represents. For example the repeated pain and disability measures will be analysed using linear mixed models. Logistic regression models with no more than 1 variable per 10 events will be used to analyse associations between prognostic factors and disability. Multivariate analysis will identify the predictive prognostic factors in the demographic, physical, social and radiological domains. The number of factors that will be entered in the multivariate analysis will be condensed by univariate pre-testing and omitting highly correlated factors. The prognostic value of both single and combined variables will be addressed by calculating sensitivity, specificity, positive and negative likelihood ratios in a standard way. Time to surgery will be modeled using Kaplan-Meier plot. Depending on number of treated patients the effect of selected covariates on time to surgery will be evaluated using the Cox model.
  2. 1) To investigate differences between patients in the observational cohort and patients treated surgically in NORDSTEN-SST and NORDSTEN-DS, by comparing baseline demographic-, clinical-, and radiological data. Patients in the NORDSTEN-OS with lumbar spinal stenosis and a verified degenerative spondylolisthesis of ≥ 3mm will be compared to patients in the NORDSTEN-DS. Patients in the NORDSTEN-OS with lumbar spinal stenosis without degenerative spondylolisthesis will be compared to patients in the NORDSTEN-SST. We will use descriptive statistics to compare the patient groups. For each of the variables we will compare measures of central tendency such as mean and median, and measures of variability such as variance and quantiles. We will also plot distributions of certain variables using histograms or fitted densities, in order to easier compare and see similarities and differences between the groups.

Baseline data Demographical data: Age, gender, BMI, education and native language. Status regarding: marriage, smoking, work and disability benefits.

Clinical data: duration of symptoms (back pain and leg pain) and use of analgetics, Patient reported outcome measures: Oswestry Disability Index (ODI 2.0), Zurich Claudication Questionnaire, EQ-5D and Numeric Rating Scale for leg pain and back pain. Hopkins symptom check list (HSCL-25) HSCL-25 is a PROM for assessment of psychological variables. It covers emotional distress, scores range from 1 to 4, with lower scores indicating less severe symptoms.

Radiological data: Standing x-rays; anterior-posterior (AP), lateral and functional images (lateral- extension and flexion) and MRI.

Radiological evaluations Standing x-ray with functional images and MRI will be performed at baseline-, 5-, and 10 years follow-up. Additionally, patients with lumbar spinal stenosis and concomitant degenerative spondylolisthesis at baseline undergo functional radiographs at 2 years follow-up. One musculoskeletal radiologist and two surgeons (Orthopedic surgeon and Neurosurgeon) will perform the radiological interpretations using Picture Archiving and Communication System (PACS), Sectra, Sweden.

MRI of the lumbar spine, including T1 and T2 sequences in the axial and sagittal planes. The following variables will be measured:

Measurements quantifying the degree of stenosis:

Morphologic grading according to the method described by Schizas et al. The grading is based on the cerebrospinal fluid/rootlet ratio, and is scaled from A-D, where A is no stenosis, B moderate stenosis, C severe stenosis and D extreme stenosis.

Measurements from sagittal plane T1 MRI sequences for grading of foraminal stenosis using the method of Lee et al.

The presence or absence of redundant nerve root sign.

Measurements when degenerative spondylolisthesis is present:

Measurement of the facet joint orientation will be done by MRI images in the transverse plan using the method of Berleman et al.

Degree of disc degeneration according to Pfirrmann et al and Modic et al. Qualitative measurement of facet joint fluid.

Qualitative measurement of disc height.

Skeletal x-rays:Standard images; frontal and lateral view of L1 to S1 in standing position.Extension- and flexion images; lateral view of L1 to S1 with respectively maximal flexion and maximal extension.

Measurement of lumbar lordosis (L1-S1),sacral slope Measurements from the radiographs for calculating vertebral sagittal olisthesis and segmental instability will use the method of Dupuis et al.

Keywords
LSS,DS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry Disability Index (ODI) version 2.0

    ODI is a patient reported outcome measure (PROM) comprising 10 sections where the patient is supposed to mark the most appropriate item. ODI scores range from 0 to 100, with higher score indicating more severe pain and disability. ODI is recommended by international expert panels for the evaluation of disability in clinical trials and commonly used by physicians treating patients with back-related symptoms. It has been translated and validated for applications with Norwegian patients. The change in ODI from baseline to follow-up will be registered.

    Measured: Baseline and follow-up at 2,5 and 10 years

Secondary outcomes (6)
  1. Zürich Claudication Questionnaire (ZCQ)

    A PROM evaluating disorder-specific functional capacity covering three domains: symptom severity (score 1-5), physical function (score 1-4), and patient satisfaction (Score 1-4) The change in ZCQ from baseline to follow-up will be registered

    Measured: Baseline and follow-up at 2,5 and 10 years

  2. Numeric Rating Scale (NRS) for back and leg pain.

    NRS is a PROM that assesses self-reported pain from 0 (no pain) to 10 (the worst pain imaginable). The change in NRS for back- and leg pain from baseline to follow-up will be registered.

    Measured: Baseline. Follow-up at 2,5 and 10 years

  3. EuroQol 5 dimensions questionnaire (EQ-5D).

    EQ-5D is a generic PROM for the evaluation of quality of life comprising 5 questions relating to mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each question has a three-point descriptive Likert-scale. Patient's answers are transformed into a scale ranging from -0.59 - 1.0 (1 equals perfect health). The change in EQ-5D from baseline to follow-up will be registered.

    Measured: Baseline and follow-up at 2,5 and 10 years

  4. Time from inclusion until time for to surgery.

    Measured: 10 years

  5. A questionnaire mapping subjective change of symptoms from baseline in a 6 point response scale, ranging from completely recovered to getting worse.

    Measured: Follow-up at 2,5 and 10 years

  6. A questionnaire mapping the satisfaction with living with the current state of symptoms for the rest of the life in a 5 point response scale, ranging from very satisfied to very dissatisfied.

    Measured: Follow-up at 2,5 and 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2018
  2. Study startFeb 2014
  3. Primary completionOct 2028 (estimated)
  4. Study completionOct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
284 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03562936
Sponsor's protocol ID
2011/2034-2
Acronym
NORDSTEN/OS
Status last verified
Aug 2021
First submitted
31 May 2018
Last updated
16 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Indrekvam K, Myklebust TA, Austevoll IM, Hermansen E, Banitalebi H, Banerud IF, Weber C, Brisby H, Brox JI, Hellum C, Storheim K. Responsiveness of the Oswestry Disability Index and Zurich Claudication Questionnaire in patients with lumbar spinal stenosis: evaluation of surgically treated patients from the NORDSTEN study. Eur Spine J. 2024 Nov;33(11):4270-4280. doi: 10.1007/s00586-024-08440-1. Epub 2024 Aug 13.

    PubMed 39134699
  • Indrekvam K, Banerud IF, Hermansen E, Austevoll IM, Rekeland F, Guddal MH, Solberg TK, Brox JI, Hellum C, Storheim K. The Norwegian degenerative spondylolisthesis and spinal stenosis (NORDSTEN) study: study overview, organization structure and study population. Eur Spine J. 2023 Dec;32(12):4162-4173. doi: 10.1007/s00586-023-07827-w. Epub 2023 Jul 3.

    PubMed 37395780

Questions about this trial

What is this clinical trial studying?

An observational study of Degenerative Lumbar Spinal Stenosis and Degenerative Spondylolisthesis, run by Haukeland University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry Disability Index (ODI) version 2.0 (time frame: Baseline and follow-up at 2,5 and 10 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03562936, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in